Trial intelligence / Profile preview

LOGAND: Long-term Cognitive Outcomes After General Anesthesia

NCT01184638Phase 4Unknown

Sponsor
Nanjing Medical University
Start
Aug 2010
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sevoflurane and propofol in delirium, Dementia, amnestic disorder and 1 more, sponsored by Nanjing Medical University. Primary endpoint: Cognitive ability at 10 years. Status: unknown.

02

Drugs

sevofluranepropofol
03

Conditions

deliriumDementiaamnestic disordercognitive disorder (CD)

Beyond the preview

Go deeper on NCT01184638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01184638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call